Tag: INO

INOVIO Announces Proposed Public Offering

PLYMOUTH MEETING, Pa., July 2, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to...

Oncology Innovation Just Hit a Turning Point — Here’s What to Watch

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape...

Oncology Innovation Just Hit a Turning Point — Here’s What to Watch

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape...

AI Is Quietly Reinventing Healthcare–And Real Deployments Are Now Underway

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that value of AI's total overhaul...

Accelerating Canada’s Semiconductor Industry: FABrIC announces $35.6M total investment from $13.4M funding in market-ready innovation

MONTREAL, June 26, 2025 /CNW/ - Twenty-three recipients representing twenty projects of the first round of FABrIC Challenge Projects were announced today. Leveraging $35.6M in...

Lithium South Environmental Impact Assessment

VANCOUVER, BC, June 25, 2025 /CNW/ -- Lithium South Development Corporation (the "Company" or "Lithium South") (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt: OGPQ) is pleased to...

Lithium South Environmental Impact Assessment

VANCOUVER, BC, June 25, 2025 /PRNewswire/ -- Lithium South Development Corporation (the "Company" or "Lithium South") (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt: OGPQ) is pleased to...

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 20, 2025 /CNW/ -- Equity Insider News Commentary – Amid the wave of new...

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core assets, including the novel drug olverembatinib (HQP1351) and the investigational EED inhibitor APG-5918, have been reported at the 2025 European Hematology Association (EHA) Annual Congress.

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsINO

Form 8.5 (EPT/RI) – Dowlais Group plc

AS Ekspress Grupp refinances bonds

One of Finland’s largest energy storage facilities commissioned in Lappeenranta – Merus Power’s EUR 15 million delivery completed

Tag: INO

INOVIO Announces Proposed Public Offering

Oncology Innovation Just Hit a Turning Point — Here’s What to Watch

Oncology Innovation Just Hit a Turning Point — Here’s What to Watch

AI Is Quietly Reinventing Healthcare–And Real Deployments Are Now Underway

Accelerating Canada’s Semiconductor Industry: FABrIC announces $35.6M total investment from $13.4M funding in market-ready innovation

Lithium South Environmental Impact Assessment

Lithium South Environmental Impact Assessment

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

As Public Cancer Funding Wavers, Oncology’s Brightest Breakthroughs Are Coming From Industry

Smart Healthcare Is Taking Over. Here’s Where the Money’s Headed

Analysts See ‘Historic Dislocation’ Between Gold Prices and Miner Valuations

Gold Miners Lag the Bullion Boom — But Not for Long, Say Wall Street Analysts

Wall Street Targets Breakout Gold Producers as Bull Market Accelerates

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us